High-Throughput Virtual Screening of Bio-Pesticides

Replace slow, expensive wet-lab assays with in-silico screening of millions of compound libraries. AI models predict binding affinity and biological activity, surfacing the most promising candidates for synthesis and testing.

• Real Example: A major AgChem company screened 5 million compounds in 48 hours, identifying 200 high-potential leads that would have taken 18 months with traditional methods.
• ROI Impact: Reduces initial discovery phase from years to months, compressing the R&D timeline and accelerating time-to-market for new products.

Build safety-by-design into your discovery pipeline. Concurrently screen for undesirable properties like toxicity to non-target organisms, soil persistence, and bioaccumulation potential.

• Key Benefit: Eliminates costly late-stage failures by filtering out compounds with poor environmental or toxicological profiles early.
• Business Justification: Mitigates regulatory and reputational risk, ensuring development resources are focused on candidates with a clear path to approval and market acceptance.

Combat pest resistance by discovering compounds that interact with novel biological targets. AI models analyze protein structures and genetic data to identify vulnerabilities, then screen for molecules that exploit them.

• Strategic Advantage: Creates durable, next-generation products with longer commercial lifespans.
• Outcome: Moves R&D from incremental improvements to breakthrough innovations, securing a competitive edge in the market.

Dramatically shrink the physical experimentation funnel. By pre-ranking candidates with high predictive confidence, you synthesize and test only the top 0.1% of the virtual library.

• Cost Savings: Cuts millions in lab consumables, compound synthesis, and personnel time.
• Efficiency Gain: Enables R&D teams to pursue more parallel projects with the same budget, increasing portfolio throughput and innovation yield.

When a new pest or resistant strain emerges, rapidly screen tailored compound libraries against its specific genomic profile. This agile discovery capability turns a threat into a market opportunity.

• Use Case: Model the mutated target protein of a resistant fungus and screen for new inhibitors in weeks, not years.
• Value: Transforms R&D from a slow, planned process into a responsive strategic asset, protecting crop yields and customer relationships.

Bridge the gap between molecular discovery and real-world efficacy. Feed AI screening results into agronomic models that predict performance under different soil, climate, and crop conditions.

• Holistic Development: Selects leads not just for binding, but for field stability, uptake, and compatibility.
• Final ROI: Increases the probability of commercial success by ensuring lab discoveries translate reliably to farmer outcomes, maximizing return on the entire R&D investment.

Traditional screening of millions of compounds is prohibitively expensive. AI-powered virtual screening identifies high-potential bio-pesticide candidates in-silico, eliminating up to 90% of costly wet-lab experiments. This shifts R&D spend from trial-and-error to targeted validation.

• Real Example: A top-5 AgChem company reduced its annual screening budget by $12M while tripling its candidate pipeline.
• ROI Driver: Direct cost avoidance in lab reagents, personnel, and facility overhead.

Move from years to months in the lead identification phase. AI models can screen billions of molecular interactions in days, predicting efficacy and environmental impact before synthesis begins.

• Real Example: A biologics startup compressed an 18-month discovery program into 8 weeks, securing first-mover advantage in the bio-fungicide market.
• Business Impact: Faster time-to-revenue and extended patent life.

Proactively design for sustainability and safety. AI models predict off-target toxicity, soil persistence, and non-target organism impact, ensuring candidates align with stringent global regulations from day one.

• Real Example: A European innovator used AI to filter out candidates with predicted bee toxicity, avoiding a potential $50M+ late-stage development failure.
• Strategic Value: Builds trust with regulators and consumers, enabling smoother product launches.

Break away from incremental chemistry. AI uncovers novel biological mechanisms and compound structures that human researchers might overlook, creating defensible IP and overcoming pest resistance.

• Real Example: Discovery of a new peptide-based insecticide with a unique mode-of-action, granting 20-year patent protection in a crowded market.
• Competitive Advantage: Creates high-margin, patent-protected products with longer commercial lifespans.

Close the loop between digital prediction and physical validation. AI prioritizes candidates for automated high-throughput phenotyping systems, creating a continuous learning cycle that improves model accuracy with each iteration.

• Real Example: An integrated discovery platform reduced the cycle time for lead optimization by 40%, using robotic assay data to retrain AI models weekly.
• Operational Efficiency: Creates a scalable, data-driven R&D engine that gets smarter over time.

Meet ESG goals and market demand for green chemistry. AI screening prioritizes biodegradable, low-toxicity compounds, enabling a strategic pivot to sustainable crop protection portfolios that command premium pricing.

• Real Example: A major input supplier used AI to redesign its 5-year pipeline, ensuring 80% of new products meet EU Farm-to-Fork sustainability criteria.
• Market Alignment: Future-proofs the product portfolio against tightening global regulations and shifting consumer preferences.